subject area of
- Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data Academic Article
- Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients Academic Article
- Causes of thrombophilia yet to be discovered: A personal view Academic Article
- Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males Academic Article
- Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide Academic Article
- Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants Academic Article
- Factor XII gene (F/2)-4C/C polymorphism in combination with low protein S activity is associated with deep vein thrombosis Academic Article
- Gain in translation: heme oxygenase-1 induced by activated protein C promotes thrombus resolution Academic Article
- Genetic variants in Cell Adhesion Molecule 1 (CADM1): A validation study of a novel endothelial cell venous thrombosis risk factor Academic Article
- High-density lipoprotein and the risk of recurrent venous thromboembolism Academic Article
- High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men Academic Article
- Inhibition of endogenous leptin protects mice from arterial and venous thrombosis Academic Article
- Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway Academic Article
- Protein c anticoagulant and cytoprotective pathways Academic Article
- The cytoprotective protein C pathway Academic Article
- Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: The CVRN VTE Study Academic Article